Kurs
+138,28%
Kurs
+138,28%
Open
69,00
High
69,00
Low
60,40
Close
61,00
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Likviditet
211 MNOK
Likviditet
211 MNOK
Rel. mcap
23,41%
Antal aktier
3 416 842
Likviditet under dagen för detta pressmeddelande
Kalender
Tid* | ||
2026-02-25 | N/A | Bokslutskommuniké 2025 |
2025-11-26 | N/A | Kvartalsrapport 2025-Q3 |
2025-08-20 | N/A | Kvartalsrapport 2025-Q2 |
2025-05-22 | N/A | Årsstämma |
2025-05-14 | N/A | Kvartalsrapport 2025-Q1 |
2025-02-26 | N/A | Bokslutskommuniké 2024 |
2024-11-27 | - | Kvartalsrapport 2024-Q3 |
2024-08-21 | - | Kvartalsrapport 2024-Q2 |
2024-05-21 | - | X-dag ordinarie utdelning NYKD 0.00 NOK |
2024-05-16 | - | Årsstämma |
2024-05-14 | - | Kvartalsrapport 2024-Q1 |
2024-02-28 | - | Bokslutskommuniké 2023 |
2023-11-15 | - | Kvartalsrapport 2023-Q3 |
2023-08-23 | - | Kvartalsrapport 2023-Q2 |
2023-05-16 | - | Kvartalsrapport 2023-Q1 |
2023-05-12 | - | X-dag ordinarie utdelning NYKD 0.00 NOK |
2023-05-11 | - | Årsstämma |
2023-02-28 | - | Bokslutskommuniké 2022 |
2022-11-23 | - | Kvartalsrapport 2022-Q3 |
2022-08-24 | - | Kvartalsrapport 2022-Q2 |
2022-05-16 | - | Kvartalsrapport 2022-Q1 |
2022-05-13 | - | X-dag ordinarie utdelning NYKD 0.00 NOK |
2022-05-12 | - | Årsstämma |
2022-03-31 | - | Bokslutskommuniké 2021 |
2021-12-22 | - | Extra Bolagsstämma 2021 |
2021-11-17 | - | Kvartalsrapport 2021-Q3 |
2021-08-26 | - | Kvartalsrapport 2021-Q2 |
2021-05-12 | - | Kvartalsrapport 2021-Q1 |
2021-05-06 | - | X-dag ordinarie utdelning NYKD 0.00 NOK |
2021-05-05 | - | Årsstämma |
2021-04-21 | - | Bokslutskommuniké 2020 |
2020-11-17 | - | Kvartalsrapport 2020-Q3 |
2020-08-27 | - | Kvartalsrapport 2020-Q2 |
2020-07-07 | - | Split NYKD 1:5 |
2020-07-06 | - | Extra Bolagsstämma |
2020-05-12 | - | Kvartalsrapport 2020-Q1 |
2020-04-22 | - | Extra Bolagsstämma |
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Bioteknik |
2020-10-07 08:55:21
Vaccibody AS (Merkur Market) Primary insider in Vaccibody AS Christian Åbyholm (board member) has through Caaby AS today purchased 20 000 shares in Vaccibody AS at a price of NOK 60 per share. After the transaction Christian Åbyholm through Caaby AS owns 1 704 720 shares. In addition Christian Åbyholm owns 100 000 options. Primary insider in Vaccibody AS Christian Åbyholm (board member) represents Andenaesgruppen. Andenaesgruppen has through Christiania Skibs AS today purchased 200 000 shares in Vaccibody AS at a price of NOK 60 per share. After the transaction Andenæsgruppen owns 15 250 000 shares. In addition Christian Åbyholm represents Norda ASA that owns 10 696 755 shares.